Volatile Week, but Green? Click to watch the new Podcast.

Corbus Pharmaceuticals Holdings Stock Forecast

NASDAQ:CRBP BUY SELL

$0.27 (4.53%)

Volume: 243.709k

Closed: Jul 05, 2022

Hollow Logo Score: -3.253

Corbus Pharmaceuticals Holdings Stock Forecast

BUY SELL NASDAQ:CRBP
$0.27 (4.53%)

Volume: 243.709k

Closed: Jul 05, 2022

Score Hollow Logo -3.253

Corbus Pharmaceuticals Holdings Stock Price (Quote) NASDAQ:CRBP

$0.27 ( 4.53% ) Tuesday, 5th Jul 2022

Range Low Price High Price Comment
30 days $0.22 $0.32 Tuesday, 5th Jul 2022 CRBP stock ended at $0.27. This is 4.53% more than the trading day before Friday, 1st Jul 2022. During the day the stock fluctuated 9.75% from a day low at $0.25 to a day high of $0.28.
90 days $0.21 $0.49
52 weeks $0.21 $1.79

Historical Corbus Pharmaceuticals Holdings prices

Date Open High Low Close Volume
2022-07-05 $0.26 $0.28 $0.25 $0.27 243 709
2022-07-01 $0.26 $0.27 $0.26 $0.26 176 606
2022-06-30 $0.26 $0.27 $0.25 $0.25 404 447
2022-06-29 $0.28 $0.28 $0.25 $0.25 837 482
2022-06-28 $0.27 $0.29 $0.26 $0.27 506 331
2022-06-27 $0.27 $0.29 $0.26 $0.27 765 196
2022-06-24 $0.30 $0.31 $0.25 $0.25 965 167
2022-06-23 $0.29 $0.29 $0.27 $0.28 531 949
2022-06-22 $0.29 $0.29 $0.27 $0.28 331 415
2022-06-21 $0.29 $0.30 $0.27 $0.29 556 003
2022-06-17 $0.25 $0.30 $0.23 $0.30 1 065 559
2022-06-16 $0.26 $0.27 $0.22 $0.23 951 269
2022-06-15 $0.25 $0.27 $0.25 $0.26 590 204
2022-06-14 $0.27 $0.28 $0.25 $0.25 473 992
2022-06-13 $0.29 $0.29 $0.26 $0.26 614 798
2022-06-10 $0.30 $0.31 $0.28 $0.29 657 272
2022-06-09 $0.29 $0.32 $0.28 $0.30 727 502
2022-06-08 $0.28 $0.30 $0.28 $0.29 426 862
2022-06-07 $0.30 $0.31 $0.27 $0.28 916 335
2022-06-06 $0.31 $0.31 $0.28 $0.30 247 926
2022-06-03 $0.29 $0.31 $0.29 $0.30 414 764
2022-06-02 $0.30 $0.30 $0.29 $0.29 355 694
2022-06-01 $0.30 $0.32 $0.27 $0.30 1 675 431
2022-05-31 $0.30 $0.31 $0.29 $0.30 1 220 804
2022-05-27 $0.30 $0.30 $0.29 $0.30 471 011
2022-05-26 $0.30 $0.31 $0.29 $0.30 986 350
2022-05-25 $0.32 $0.33 $0.29 $0.30 708 373
2022-05-24 $0.32 $0.33 $0.30 $0.31 412 150
2022-05-23 $0.32 $0.33 $0.30 $0.31 1 084 047
2022-05-20 $0.35 $0.36 $0.32 $0.34 1 281 471
2022-05-19 $0.33 $0.36 $0.33 $0.35 1 301 291
2022-05-18 $0.31 $0.35 $0.29 $0.33 3 227 485
2022-05-17 $0.28 $0.31 $0.28 $0.30 1 604 025
2022-05-16 $0.25 $0.41 $0.23 $0.30 30 735 323
2022-05-13 $0.23 $0.24 $0.21 $0.21 5 002 306
2022-05-12 $0.23 $0.24 $0.21 $0.21 2 111 918
2022-05-11 $0.27 $0.28 $0.23 $0.24 682 603
2022-05-10 $0.30 $0.30 $0.25 $0.26 817 432
2022-05-09 $0.31 $0.31 $0.26 $0.27 898 088
2022-05-06 $0.32 $0.32 $0.29 $0.29 955 666
2022-05-05 $0.33 $0.34 $0.32 $0.32 382 004
2022-05-04 $0.35 $0.35 $0.32 $0.33 443 547
2022-05-03 $0.34 $0.35 $0.33 $0.34 276 040
2022-05-02 $0.34 $0.34 $0.32 $0.34 355 978
2022-04-29 $0.34 $0.35 $0.33 $0.34 201 776
2022-04-28 $0.35 $0.36 $0.32 $0.35 355 526
2022-04-27 $0.34 $0.36 $0.33 $0.34 551 270
2022-04-26 $0.34 $0.35 $0.33 $0.33 544 667
2022-04-25 $0.36 $0.37 $0.33 $0.35 717 913
2022-04-22 $0.37 $0.38 $0.35 $0.35 389 831

IMPROVE YOUR TRADING GAME WITH A GOLDEN STAR

From 26 533 stocks, only a few dozen will trigger such a signal!

About Corbus Pharmaceuticals Holdings

Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases. Its lead product candidate includes Resunab, a novel oral endocannabinoid-mimetic drug, which is in Phase 2 clinical trials for the treatment of cystic fibrosis, systemic sclerosis, and skin-predominant dermatomyositis diseases. The company is based in N... Read more

.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT